[go: up one dir, main page]

GB0021008D0 - Protein and nucleic acid sequence - Google Patents

Protein and nucleic acid sequence

Info

Publication number
GB0021008D0
GB0021008D0 GBGB0021008.8A GB0021008A GB0021008D0 GB 0021008 D0 GB0021008 D0 GB 0021008D0 GB 0021008 A GB0021008 A GB 0021008A GB 0021008 D0 GB0021008 D0 GB 0021008D0
Authority
GB
United Kingdom
Prior art keywords
protein
nucleic acid
acid sequence
sequence
nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0021008.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SECR DEFENCE
UK Secretary of State for Defence
Original Assignee
SECR DEFENCE
UK Secretary of State for Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SECR DEFENCE, UK Secretary of State for Defence filed Critical SECR DEFENCE
Priority to GBGB0021008.8A priority Critical patent/GB0021008D0/en
Publication of GB0021008D0 publication Critical patent/GB0021008D0/en
Priority to PCT/GB2001/003835 priority patent/WO2002018600A1/en
Priority to AU2001282350A priority patent/AU2001282350A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB0021008.8A 2000-08-26 2000-08-26 Protein and nucleic acid sequence Ceased GB0021008D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0021008.8A GB0021008D0 (en) 2000-08-26 2000-08-26 Protein and nucleic acid sequence
PCT/GB2001/003835 WO2002018600A1 (en) 2000-08-26 2001-08-24 Groes and groel homologs of francisella tularensis
AU2001282350A AU2001282350A1 (en) 2000-08-26 2001-08-24 Groes and groel homologs of francisella tularensis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0021008.8A GB0021008D0 (en) 2000-08-26 2000-08-26 Protein and nucleic acid sequence

Publications (1)

Publication Number Publication Date
GB0021008D0 true GB0021008D0 (en) 2000-10-11

Family

ID=9898323

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0021008.8A Ceased GB0021008D0 (en) 2000-08-26 2000-08-26 Protein and nucleic acid sequence

Country Status (3)

Country Link
AU (1) AU2001282350A1 (en)
GB (1) GB0021008D0 (en)
WO (1) WO2002018600A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0212666D0 (en) 2002-05-31 2002-07-10 Secr Defence Immunogenic sequences
GB0214942D0 (en) * 2002-06-28 2002-08-07 Secr Defence Immunogenic proteins and DNA encoding these
US20050089509A1 (en) * 2003-09-12 2005-04-28 Board Of Regents, The University Of Texas System Treatment of Francisella infection with an IFN-gamma inducer and a chemotherapeutic agent
EP2040744B1 (en) 2006-07-25 2016-03-09 The Secretary of State for Defence Live vaccine strains of francisella
GB0906234D0 (en) 2009-04-14 2009-05-20 Secr Defence Vaccine

Also Published As

Publication number Publication date
AU2001282350A1 (en) 2002-03-13
WO2002018600A1 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
AU4141101A (en) Nucleic acids, proteins, and antibodies
AU4341502A (en) Nod2 nucleic acids and proteins
AU5077101A (en) Nucleic acids, proteins, and antibodies
IL162274A0 (en) A nucleic acid and protein designated 193p1e1b andcompositions containing the same
IL130608A0 (en) Novel nucleic and amino acid sequence
EP1186615A4 (en) Novel protein and dna thereof
AU2001296301A8 (en) Nucleic acids, proteins, and antibodies
AU8308901A (en) Novel proteins and nucleic acids encoding same
AU1181802A (en) Novel proteins and nucleic acids encoding same
AU2735002A (en) Nod2 nucleic acids and proteins
AU2001274566A1 (en) Novel protein and dna thereof
EP1383533A4 (en) Proteins and nucleic acids encoding same
GB0021008D0 (en) Protein and nucleic acid sequence
EP1409683A4 (en) i HELICOBACTER /i PROTEINS, NUCLEIC ACIDS AND USES THEREOF
AU3095801A (en) Nucleic acids, proteins, and antibodies
GB0020952D0 (en) Genes and proteins and their uses
AU2001259240A1 (en) Novel stmst protein and nucleic acid mocecules and uses therefor
AU3099402A (en) Novel proteins and nucleic acids encoding same
EP1142999A4 (en) Novel protein and dna thereof
EP1111047A4 (en) Novel protein and dna thereof
AU2001241414A8 (en) Nucleic acids, proteins, and antibodies
GB0122304D0 (en) Proteins and nucleic acids
GB0107627D0 (en) Proteins and nucleic acids
AU1663702A (en) Proteins and nucleic acids encoding same
AU2002246696A8 (en) Proteins and nucleic acids encoding same

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)